Ivana Parker, Ph.D., to receive the inaugural A. Oveta Fuller Award

Portrait photo of Dr. Ivana Parker, recipient of the A. Ovata Fuller Award, September 2024

The inaugural A. Oveta Fuller Award was recently awarded to Ivana Parker, Ph.D., assistant professor in the Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida (UF).

Parker will present a seminar on October 31, 2024, in Ann Arbor, Michigan.

The A. Oveta Fuller Award is a career development award for emerging leaders in the areas of microbiology and immunology, infectious disease, or health disparities whose goals and accomplishments benefit society in the spirit of A. Oveta Fuller, Ph.D., who until her untimely death in 2022, was a virologist and scientific trailblazer on the faculty at the University of Michigan and an ordained elder in the African Methodist Episcopal Church.

In 1988, Fuller was the first Black woman to be hired into the Department of Microbiology and Immunology at the University of Michigan.

Much like Fuller, who worked extensively on HIV education and prevention in Zambia and South Africa, Parker is passionate about alleviating the burden of HIV in disproportionately affected communities of women.

Her lab employs multi-omics, systems biology, immunology, and computational approaches to characterize immune responses to pathogenic stimuli known to increase HIV risk. She is particularly interested in how vaginal microbes interact with host cells and how this increases risk for diseases. 

In 2018–2019, Parker was a Fulbright Scholar, completing a year-long study at the University of Cape Town in South Africa. There she worked to alleviate mother to child transmission of HIV by unveiling mechanisms of immune activation in BCG-vaccinated infants.

She sought to empower vulnerable young women through science education and mentoring programs in collaboration with Baleka Wellness, a fitness program founded in South Africa to improve emotional, mental, and physical health for vulnerable youth.

During her post-doctoral work, she became aware of hard-to-treat diagnoses, such as bacterial vaginosis (BV), that dramatically increase the risk of HIV acquisition, affect women globally, and lack effective therapeutic strategies.

“The award’s committee and Dr. Fuller’s family are pleased to recognize Dr. Parker with this award in memory of our dear colleague, wife and mother,” said Beth Moore, Ph.D., Nancy Williams Walls Professor and Chair of the Department of Microbiology and Immunology.

“We were impressed with the clear parallels between Dr. Parker’s work and Dr. Fuller’s legacy. We are delighted that Dr. Parker shares Dr. Fuller’s passion for research that impacts marginalized communities, public health and has the ability to leverage faith relationships to improve health outcomes.”

Prior to being a Fulbright Scholar, Parker was a postdoctoral fellow of the American Society for Microbiology at the Centers for Disease Control and Prevention (CDC) within the Division of HIV/AIDS Prevention. At CDC, she evaluated the impact of antiretroviral therapy on diagnostic assay approaches and identified trends to optimize assay design. 

Parker received her M.S. in mechanical engineering and a Ph.D. in bioengineering from the Georgia Institute of Technology in 2013 and 2015, respectively. Her doctoral thesis investigated the effects of pro-atherogenic shear stress, HIV proteins, and antiretroviral therapies on the vasculature using in vivo and in vitro models.

During her time at Georgia Tech, she received an NSF graduate research fellowship and was selected to be a trainee on an NIH Cell and Tissue Engineering Training Grant. She was also awarded a summer grant from the Whitaker International Program to develop artificial aortic valves in Cape Town, South Africa.

Her recent awards include the 2023 UF “40 under 40” Award , and a UF International Center Global Fellowship in 2021. She is first author in peer-reviewed journals such as JAIDS (2018) and the Journal of Immunological Methods (2017). 

Dr. Ivana Parker, Hiking Table Mountain with a group of youth from Gugulethu township , and her children. Foundational activities for Baleka Wellness (founded by her husband), where she mentored several young women, encouraging them to pursue careers in science and advocating for education and wellness.

Hiking Table Mountain with a group of youth from Gugulethu township and her children. Hiking is a foundational activity for Baleka Wellness, an organization where she mentored several young women, encouraging them to pursue careers in science and advocating for education and wellness.

 

Dr. Parker and her family in South Africa, by a quote that inspired Dr. Parker throughout her journey.

Dr. Parker and her family in South Africa, by a quote that inspired Dr. Parker throughout her journey.

Featured News & Stories headshot of Carrie Ferrario
Department News
ORTDD career development spotlight featuring Dr. Carrie Ferrario
ORTDD career development spotlight featuring Dr. Carrie Ferrario
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
IUD 101
IUDs are becoming one of the most popular forms of birth control for all ages. In this episode, we cover a recent Health Lab article Q&A on IUDs with Dr. Monica Rosen of University of Michigan Health.
man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
surgical area of clinicians drawn out with blue background
Health Lab
New tools that leverage NIH’s ‘All of Us’ dataset could improve anesthesia and surgical care
In a report in JAMA Surgery, researchers propose two novel tools that leverage the All of Us dataset to look at acute health events such as surgery.
Dr. Adina Turcu
Department News
Internal Medicine Faculty Spotlight − Dr. Adina Turcu
Adina Turcu, MD, MS is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes, dedicated to providing comprehensive and compassionate care to her patients.
prescription pad drawn
Health Lab
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.